SCHEMBL6913785

SCHEMBL6913785

COc1ccc(N2CCN(C)CC2)c2c1OCC(OC(=O)Nc1ccc(N3CCOCC3)cc1)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1B P28222 10/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ MAPT P10636 5/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ MTOR P42345 1/20 0.46
▸ RAD52 P43351 1/20 0.44
▸ HTR1A P08908 6/20 0.44
▸ HTR1D P28221 6/20 0.44
▸ HTR2A P28223 4/20 0.43
▸ HTR2C P28335 3/20 0.43
▸ HTR6 P50406 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ GAA P10253 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6820063 0.86 HTR1B (0.53) HTR1BKCNH2MAPTRAB9ANPC1
SCHEMBL7062951 0.85 HTR1B (0.52) HTR1BKCNH2MAPTRAB9ANPC1
SCHEMBL7063741 0.85 HTR1B (0.52) HTR1BKCNH2MAPTRAB9ANPC1
SCHEMBL7063234 0.85 HTR1B (0.52) HTR1BKCNH2MAPTRAB9ANPC1
SCHEMBL6569460 0.79 GAA (0.49) HTR1BKCNH2MAPTRAB9ANPC1
SCHEMBL6816431 0.74 HTR1B (0.58) HTR1BKCNH2MAPTRAB9ANPC1
SCHEMBL6816422 0.74 HTR1B (0.58) HTR1BKCNH2MAPTRAB9ANPC1
SCHEMBL6816404 0.74 HTR1B (0.58) HTR1BKCNH2MAPTRAB9ANPC1
SCHEMBL6819644 0.72 MAPT (0.55) MAPTRAB9ANPC1KMT2APOLB
SCHEMBL6824086 0.71 HTR1B (0.56) HTR1BKCNH2MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1014986-B1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT 1 BETA ANTAGONIST OR PARTIAL AGONIST ASTRAZENECA AB (SE) 2004-07-14 — — EP claimed
EP-1025096-B1 SUBSTITUTED CHROMAN DERIVATIVES ASTRAZENECA AB (SE) 2003-11-26 — — EP claimed
EP-1014985-B1 A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A H5-HT 1B ANTAGONIST OR PARTIAL AGONIST ASTRAZENECA AB (SE) 2003-05-21 — — EP claimed
Send feedback